Loading...
XSHE
300765
Market cap11bUSD
Apr 09, Last price  
38.27CNY
1D
3.68%
1Q
56.97%
IPO
353.75%
Name

CSPC Innovation Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
119.87
P/S
36.20
EPS
0.32
Div Yield, %
1.07%
Shrs. gr., 5y
9.66%
Rev. gr., 5y
15.07%
Revenues
2.50b
-4.75%
650,715,959742,010,176890,477,1971,031,180,9651,240,098,6911,256,502,3591,317,414,1221,431,987,6642,626,488,8322,501,699,905
Net income
756m
+4.03%
108,235,384115,590,425206,576,912194,911,146223,840,143273,197,126299,835,756393,228,489726,277,891755,557,253
CFO
927m
+44.72%
93,362,300112,048,300137,266,7311,300,210159,727,619315,384,186349,071,664170,592,336640,717,518927,241,226
Dividend
Apr 25, 20240.384 CNY/sh

Profile

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.
URL
http://www.xnwpharma.net/
IPO date
Mar 22, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,501,700
-4.75%
2,626,489
83.42%
Cost of revenue
1,600,847
1,800,301
Unusual Expense (Income)
NOPBT
900,853
826,188
NOPBT Margin
36.01%
31.46%
Operating Taxes
136,470
124,761
Tax Rate
15.15%
15.10%
NOPAT
764,383
701,427
Net income
755,557
4.03%
726,278
84.70%
Dividends
(97,848)
(97,562)
Dividend yield
0.23%
1.00%
Proceeds from repurchase of equity
483,919
(69)
BB yield
-1.13%
0.00%
Debt
Debt current
223
Long-term debt
1,682
19,800
Deferred revenue
33,258
37,208
Other long-term liabilities
1
Net debt
(3,420,490)
(2,429,151)
Cash flow
Cash from operating activities
927,241
640,718
CAPEX
(95,732)
Cash from investing activities
(92,986)
311,878
Cash from financing activities
365,206
FCF
819,801
272,266
Balance
Cash
3,422,173
2,195,684
Long term investments
253,489
Excess cash
3,297,088
2,317,849
Stockholders' equity
4,017,460
2,806,623
Invested Capital
1,824,174
1,644,127
ROIC
44.08%
46.04%
ROCE
17.59%
20.85%
EV
Common stock shares outstanding
1,170,522
1,114,067
Price
36.62
317.72%
8.77
2.87%
Market cap
42,864,510
338.89%
9,766,655
16.61%
EV
39,452,374
7,346,098
EBITDA
1,000,950
899,132
EV/EBITDA
39.41
8.17
Interest
640
219
Interest/NOPBT
0.07%
0.03%